Profile | GDS5420 / 233818_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 288.78 | 58 |
GSM1296119 | B_lesional_pre-dose | 182.9 | 50 |
GSM1296076 | C_lesional_pre-dose | 158.47 | 50 |
GSM1296092 | D_lesional_pre-dose | 105.05 | 44 |
GSM1296103 | E_lesional_pre-dose | 168.39 | 50 |
GSM1296078 | F_lesional_pre-dose | 232.97 | 57 |
GSM1296107 | G_lesional_pre-dose | 259.02 | 56 |
GSM1296109 | H_lesional_pre-dose | 177.55 | 49 |
GSM1296080 | I_lesional_pre-dose | 206.07 | 54 |
GSM1296090 | J_lesional_pre-dose | 115.79 | 45 |
GSM1296074 | K_lesional_pre-dose | 131.19 | 48 |
GSM1296111 | L_lesional_pre-dose | 185.55 | 50 |
GSM1296099 | M_lesional_pre-dose | 242.57 | 55 |
GSM1296086 | O_lesional_pre-dose | 140.09 | 48 |
GSM1296117 | P_lesional_pre-dose | 184.46 | 50 |
GSM1296113 | Q_lesional_pre-dose | 217.79 | 52 |
GSM1296096 | R_lesional_pre-dose | 210.25 | 53 |
GSM1296105 | S_lesional_pre-dose | 268.16 | 56 |
GSM1296098 | T_lesional_pre-dose | 323.41 | 60 |
GSM1296101 | U_lesional_pre-dose | 242.54 | 55 |
GSM1296121 | V_lesional_pre-dose | 186.21 | 51 |
GSM1296088 | W_lesional_pre-dose | 189.3 | 52 |
GSM1296082 | X_lesional_pre-dose | 154.74 | 50 |
GSM1296115 | Y_lesional_pre-dose | 202.73 | 52 |
GSM1296084 | Z_lesional_pre-dose | 164.53 | 49 |
GSM1296072 | B_lesional_day8 | 171.39 | 49 |
GSM1296069 | L_lesional_day8 | 202.71 | 51 |
GSM1296071 | P_lesional_day8 | 176.09 | 48 |
GSM1296070 | Y_lesional_day8 | 191.13 | 50 |
GSM1296073 | V_lesional_day8 | 119.29 | 44 |
GSM1296034 | A_lesional_day15 | 207.41 | 52 |
GSM1296041 | G_lesional_day15 | 181.61 | 50 |
GSM1296035 | R_lesional_day15 | 121.7 | 45 |
GSM1296038 | U_lesional_day15 | 229.04 | 55 |
GSM1296047 | B_lesional_day15 | 198.44 | 51 |
GSM1296039 | E_lesional_day15 | 123.85 | 45 |
GSM1296042 | H_lesional_day15 | 165.79 | 48 |
GSM1296043 | L_lesional_day15 | 256.62 | 55 |
GSM1296037 | M_lesional_day15 | 143.51 | 46 |
GSM1296046 | P_lesional_day15 | 194.63 | 50 |
GSM1296044 | Q_lesional_day15 | 203.16 | 51 |
GSM1296045 | Y_lesional_day15 | 185.88 | 49 |
GSM1296025 | C_lesional_day15 | 235.88 | 56 |
GSM1296033 | D_lesional_day15 | 169.71 | 50 |
GSM1296027 | I_lesional_day15 | 145.25 | 49 |
GSM1296032 | J_lesional_day15 | 200.83 | 52 |
GSM1296024 | K_lesional_day15 | 235.04 | 56 |
GSM1296031 | W_lesional_day15 | 153.81 | 47 |
GSM1296028 | X_lesional_day15 | 152.7 | 48 |
GSM1296029 | Z_lesional_day15 | 130.53 | 46 |
GSM1296026 | F_lesional_day15 | 261.65 | 58 |
GSM1296030 | O_lesional_day15 | 90.29 | 43 |
GSM1296040 | S_lesional_day15 | 176.67 | 50 |
GSM1296036 | T_lesional_day15 | 268.38 | 56 |
GSM1296048 | V_lesional_day15 | 133.02 | 45 |
GSM1296059 | A_lesional_day43 | 138.7 | 47 |
GSM1296066 | G_lesional_day43 | 202.55 | 51 |
GSM1296060 | R_lesional_day43 | 187.35 | 51 |
GSM1296063 | U_lesional_day43 | 178.68 | 50 |
GSM1296064 | E_lesional_day43 | 183.09 | 52 |
GSM1296067 | H_lesional_day43 | 177.04 | 48 |
GSM1296062 | M_lesional_day43 | 213.54 | 53 |
GSM1296068 | Q_lesional_day43 | 151.39 | 45 |
GSM1296050 | C_lesional_day43 | 271.29 | 58 |
GSM1296057 | D_lesional_day43 | 107.11 | 43 |
GSM1296052 | I_lesional_day43 | 154.1 | 50 |
GSM1296054 | J_lesional_day43 | 186.87 | 51 |
GSM1296049 | K_lesional_day43 | 216.67 | 54 |
GSM1296055 | W_lesional_day43 | 171.22 | 49 |
GSM1296053 | X_lesional_day43 | 262.88 | 57 |
GSM1296058 | Z_lesional_day43 | 76.55 | 38 |
GSM1296051 | F_lesional_day43 | 191.85 | 53 |
GSM1296056 | O_lesional_day43 | 115.84 | 45 |
GSM1296065 | S_lesional_day43 | 157.97 | 48 |
GSM1296061 | T_lesional_day43 | 159.13 | 48 |
GSM1296095 | A_non-lesional_pre-dose | 188.13 | 52 |
GSM1296120 | B_non-lesional_pre-dose | 234.24 | 54 |
GSM1296077 | C_non-lesional_pre-dose | 212.68 | 54 |
GSM1296093 | D_non-lesional_pre-dose | 217.38 | 53 |
GSM1296104 | E_non-lesional_pre-dose | 179.42 | 50 |
GSM1296079 | F_non-lesional_pre-dose | 299.53 | 60 |
GSM1296108 | G_non-lesional_pre-dose | 225.33 | 54 |
GSM1296110 | H_non-lesional_pre-dose | 242.46 | 54 |
GSM1296081 | I_non-lesional_pre-dose | 213.89 | 55 |
GSM1296091 | J_non-lesional_pre-dose | 140.43 | 48 |
GSM1296075 | K_non-lesional_pre-dose | 129.92 | 47 |
GSM1296112 | L_non-lesional_pre-dose | 244.31 | 54 |
GSM1296100 | M_non-lesional_pre-dose | 266.07 | 56 |
GSM1296087 | O_non-lesional_pre-dose | 102.53 | 44 |
GSM1296118 | P_non-lesional_pre-dose | 250.6 | 55 |
GSM1296114 | Q_non-lesional_pre-dose | 216.62 | 52 |
GSM1296097 | R_non-lesional_pre-dose | 198.19 | 52 |
GSM1296106 | S_non-lesional_pre-dose | 283.09 | 57 |
GSM1296102 | U_non-lesional_pre-dose | 144.19 | 46 |
GSM1296122 | V_non-lesional_pre-dose | 200.46 | 51 |
GSM1296089 | W_non-lesional_pre-dose | 172.57 | 49 |
GSM1296083 | X_non-lesional_pre-dose | 244.6 | 55 |
GSM1296116 | Y_non-lesional_pre-dose | 247.67 | 54 |
GSM1296085 | Z_non-lesional_pre-dose | 117.74 | 44 |